Back to Trades
Stelmakh Edward
Chief Finance & Strat OfficerCIK 0001887046
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 6 filings between 2025–2026, Stelmakh Edward, Chief Finance & Strat Officer, has disclosed $744.8K in transactions — all concentrated in OptimizeRx Corp (OPRX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $18.8K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Aug 24 | OPRX OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | Tax withheld | $10.6K |
| Dec 23 | OPRX OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | Tax withheld | $46.6K |
| Dec 23 | OPRX OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | Exercise | $18.8K |
| Dec 22 | OPRX OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | Sell | $18.8K |
| Oct 7 | OPRX OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | Exercise | $82.6K |
| Aug 25 | OPRX OptimizeRx Corp | Stelmakh Edward | CFO/COO | Grant | $567.4K |
6 filings